Medical/Surgical/Diseases/Complications
Poster Session 1
Tiffany Yang, MD
Maternal Fetal Medicine Fellow
Stony Brook University
Stony Brook, NY
Julia Kim, MD
Stony Brook University Hospital
Stony Brook, NY, United States
Emily H. Stetler, MD (she/her/hers)
Maternal Fetal Medicine Fellow Physician
Stony Brook University Hospital
Stony Brook, NY, United States
Christy Chan, BA
Stony Brook Medicine
Stony Brook, NY, United States
Oladunni Ogundipe, MD (she/her/hers)
Resident
Stony Brook University Hospital
Stony Brook, NY, United States
Chaitali Korgaonkar-Cherala, MD, MS (she/her/hers)
Resident Physician
Stony Brook University Hospital
Coram, New York, United States
Lauren Stewart, MD (she/her/hers)
Resident
Stony Brook University Hospital
Stony Brook, NY, United States
Erika Zambrano Alvarez, BA
Stony Brook Medicine
Stony Brook, NY, United States
Gabriella Lo Monaco, BS
Renaissance School of Medicine at Stony Brook University
Stony Brook, NY, United States
Kimberly Herrera, MD
Stony Brook University Hospital
Stony Brook, NY, United States
David Garry, DO
Maternal Fetal Medicine
Stony Brook Medicine
Stony Brook, NY, United States
Diana Garretto, MD
Assistant Professor
Stony Brook University Hospital
E Northport, NY, United States
Cassandra Heiselman, DO, MPH (she/her/hers)
Clinical Assistant Professor
Stony Brook Medicine
Stony Brook, NY, United States
Pregnancies affected by maternal opioid use disorder (MOUD) face difficulties with postpartum pain control and Neonatal Opioid Withdrawal Syndrome (NOWS). This study aims to determine if prenatal anesthesia consultation for MOUD patients affects maternal and fetal outcomes.
Study Design: This is a retrospective cohort study of pregnant patients diagnosed with MOUD who received prenatal care and delivered at an academic institution between January 2017 and July 2023. Subjects were divided into those who received prenatal anesthesia consultation and those who did not. Severe pain on a numerical rating scale was defined as score >7. Statistical analysis was performed using Mann-Whitney U test with statistical significance defined as p< 0.05.
Results: The cohort included 324 women with MOUD. Of these, 15.7% (N=51) received anesthesia consultation and 84.3% (N=273) did not. When comparing pain scores in the first 24 hours postpartum, patients with prenatal anesthesia consultation had statistically significant lower rates of severe pain compared to those who did not (26% vs. 45.3%, p=0.01). Neonatal outcomes were assessed; though NOWS diagnoses were not associated with prenatal anesthesia consultation, NICU admissions were significantly fewer for patients who had anesthesia referral (p=0.01). Factors found to have significant association with prenatal anesthesia consultation were care with an obstetric provider with training in maternal opioid care (p< 0.01) and a higher number of prenatal care visits (10.3 vs. 8.9, p=0.02).
Conclusion: MOUD patients who received anesthesia consultation in pregnancy reported lower postpartum pain scores than those without consultation. Our data supports multidisciplinary care including prenatal anesthesia consultation for MOUD patients.